Curaleaf Holdings, Inc.

Shares of small-cap marijuana company Curaleaf Holdings, whose 2018 IPO <a href="https://www.forbes.com/sites/rachelsandler/2019/09/10/cannabis-king-boris-jordan-chairman-of-curaleaf-becomes-the-only-pot-billionaire/">turned</a>&nbsp;majority shareholder Boris Jordan into a billionaire, <a href="https://finance.yahoo.com/quote/CURLF/">rose</a>&nbsp;nearly 10% in over-the-counter trading yesterday, August 21. The rally was fueled by a <a href="https://www.marijuanamoment.net/cbd-has-potential-to-treat-alcohol-use-disorder-by-reducing-withdrawal-symptoms-and-lowering-relapse-risk-federally-funded-study-finds/">scientific study</a> suggesting that a substance found in marijuana, cannabidiol (CBD), may help treat alcoholism, according to the <a href="https://www.fool.com/investing/2025/08/21/why-curaleaf-stock-wafted-almost-10-higher-today/">Motley Fool</a>. It thinks that further successful studies could lead to "something of a revival" in demand for CBD.

Curaleaf shares jump 10% on upbeat study on medical uses of CBD

Village Farms International, Inc.

Canopy Growth Corporation

Tilray Brands, Inc.

Shares of cannabis companies surged by double digits yesterday, August 11, driven by a <a href="https://www.bloomberg.com/news/articles/2025-08-11/pot-stocks-soar-on-report-trump-mulling-drug-reclassification?srnd=homepage-europe">comment</a>&nbsp;from U.S. President Trump that he is considering reclassifying the drug, on the federal level, as less dangerous. Analysts say the move could reinvigorate the industry, spur research, and open up new market opportunities.

Cannabis stocks soar as Trump hints at relaxing U.S. federal law

The marijuana investment boom in the stock market has come to an end, <a href="https://www.bloomberg.com/news/articles/2025-06-09/pot-stock-euphoria-vanishes-as-us-legalization-remains-elusive?sref=Y0jVLcFo">writes</a> Bloomberg. Interest in what appeared to be a promising industry is fading following hopes for federal legalization of cannabis in the United States. Investors still waiting for profits are missing opportunities to make money on other assets, analysts say;

#Cannabis: 3

Curaleaf shares jump 10% on upbeat study on medical uses of CBD

Cannabis stocks soar as Trump hints at relaxing U.S. federal law

Bloomberg: The cannabis investment boom is over. What should investors expect?